These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 6303073

  • 1. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW, Heikes JE, Harris DN, Greenberg R.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW, Morton HE, Fortin R, Yoakim C, Girard Y, Lord A, Ethier D, Leveille C, Letts G, Evans J.
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR.
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract] [Full Text] [Related]

  • 6. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
    Nakane M, Reid JA, Haslanger MF, Garber DP, Harris DN, Ogletree ML, Greenberg R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jan; 15():291-3. PubMed ID: 3004140
    [No Abstract] [Full Text] [Related]

  • 7. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR, Fitzpatrick FA, Miller OV.
    Adv Cyclic Nucleotide Res; 1978 Jan; 9():597-609. PubMed ID: 208399
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC, Magolda RL, Smith JB, Aharony D, Smith EF, Lefer AM.
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH, Jones RL.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jun; 14():393-425. PubMed ID: 2992245
    [No Abstract] [Full Text] [Related]

  • 10. A structural analog of thromboxane A2.
    Ansell MF, Caton MP, Palfreyman MN, Stuttle KA, Tuffin D, Walker JL.
    Adv Prostaglandin Thromboxane Res; 1980 Jun; 6():485-7. PubMed ID: 7386282
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Res; 1980 Jun; 6():417-25. PubMed ID: 6247892
    [No Abstract] [Full Text] [Related]

  • 12. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S, Oliva D, Bernini F, Fumagalli R.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Jun; 17():593-9. PubMed ID: 6328938
    [No Abstract] [Full Text] [Related]

  • 13. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB, Araki H, Lefer AM.
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR, Maxey KM, Bundy GL.
    Biochem Biophys Res Commun; 1981 May 15; 100(1):184-90. PubMed ID: 7196228
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V, De Gaetano G.
    Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP, Hallet P, Hornby EJ, Wallis CJ, Collington EW, Lumley P.
    Circulation; 1990 Jan 03; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S, Vane JR.
    Pharmacol Rev; 1978 Sep 03; 30(3):293-331. PubMed ID: 116251
    [No Abstract] [Full Text] [Related]

  • 18. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
    Hamanaka N, Ohuchida S, Hayashi M.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Sep 03; 11():319-22. PubMed ID: 6221543
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological interactions between prostacyclin and thromboxanes.
    Whittle BJ, Moncada S.
    Br Med Bull; 1983 Jul 03; 39(3):232-8. PubMed ID: 6313114
    [No Abstract] [Full Text] [Related]

  • 20. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
    Peskar BA, Förstermann U, Simmet T.
    Artery; 1980 Jul 03; 8(1):1-6. PubMed ID: 7000038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.